Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | J Bendell F Ciardiello J Tabernero N Tebbutt C Eng M Di Bartolomeo A Falcone M Fakih M Kozloff N Segal A Sobrero Y Shi L Roberts Y Yan I Chang A Uyei T Kim | ||||||||||||
Title | Efficacy and safety results from IMblaze370, a randomised Phase III study comparing atezolizumab+cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy-refractory metastatic colorectal cancer | ||||||||||||
|
|||||||||||||
URL | https://academic.oup.com/annonc/article/29/suppl_5/mdy208.003/5043313 | ||||||||||||
Abstract Text | Annals of Oncology, Volume 29, Issue suppl_5, 1 June 2018 |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|